Yatham L N
Department of Psychiatry, Dalhousie University, Nova Scotia Hospital, Dartmouth, Canada.
Biol Psychiatry. 1996 Feb 15;39(4):285-8. doi: 10.1016/0006-3223(95)00133-6.
Prolactin and cortisol responses to fenfluramine (60 mg PO) challenge were examined in 20 subjects (10 manic patients and 10 age- and gender-matched healthy controls) to ascertain the "net" central serotonin (5-HT) activity in mania. There was no difference in baseline prolactin or cortisol levels between manic patients and healthy controls. Similarly, neither prolactin nor cortisol response to fenfluramine was different in manic patients compared to controls. There was also no correlation between severity of symptoms in manic patients and prolactin or cortisol response to fenfluramine challenge. The results do not support the possibility that net central 5-HT activity is altered in mania.
对20名受试者(10名躁狂症患者和10名年龄及性别匹配的健康对照者)进行了催乳素和皮质醇对芬氟拉明(口服60毫克)激发试验的反应检测,以确定躁狂症患者的“净”中枢5-羟色胺(5-HT)活性。躁狂症患者与健康对照者的基线催乳素或皮质醇水平没有差异。同样,与对照组相比,躁狂症患者对芬氟拉明的催乳素和皮质醇反应也没有差异。躁狂症患者的症状严重程度与对芬氟拉明激发试验的催乳素或皮质醇反应之间也没有相关性。结果不支持躁狂症患者中枢5-HT净活性发生改变的可能性。